International Clinical Trial: Synergistic Effects and Frontal Electroencephalographic Spectral Characteristics of Remimazolam Combined With Sufentanil Sedation: A Prospective, Single-Center, Self-Controlled Pre-Post Observational Study

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119956) titled 'Synergistic Effects and Frontal Electroencephalographic Spectral Characteristics of Remimazolam Combined With Sufentanil Sedation: A Prospective, Single-Center, Self-Controlled Pre-Post Observational Study' on March 6.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The Second Xiangya Hospital, Central South University

Condition: none

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-06

Target Sample Size: Trial group:60;

Countries of Recruitment: Chian

To know more, visit https://www.chictr.org.cn/showproj.html?proj=312710

Published by HT Digit...